[
  {
    "title": "成大生物：b型流感嗜血杆菌(Hib)结合疫苗进入Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/12/28155937243131.shtml",
    "datetime": "2022-12-28 15:59:50",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：b型流感嗜血杆菌(Hib)结合疫苗进入Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/12/28155237243147.shtml",
    "datetime": "2022-12-28 15:52:25",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：部分董事、高管累计增持10.48万股",
    "href": "http://stock.jrj.com.cn/2022/11/29174637175016.shtml",
    "datetime": "2022-11-29 17:46:26",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：拟使用不超27.5亿元的暂时闲置募资进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/11/11163537131509.shtml",
    "datetime": "2022-11-11 16:35:16",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：ACYW135群脑膜炎球菌多糖结合疫苗获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/08164237120626.shtml",
    "datetime": "2022-11-08 16:42:36",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：部分董事、高管拟增持690万元-1380万元公司股份",
    "href": "http://stock.jrj.com.cn/2022/10/30214837097910.shtml",
    "datetime": "2022-10-30 21:48:16",
    "code": "688739"
  },
  {
    "title": "成大生物2022年前三季度净利5.89亿同比减少28.90% 销售及管理费用增加",
    "href": "http://stock.jrj.com.cn/2022/10/24203237079349.shtml",
    "datetime": "2022-10-24 20:32:44",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)第三季度净利润2.08亿元",
    "href": "http://stock.jrj.com.cn/2022/10/24162637078109.shtml",
    "datetime": "2022-10-24 16:26:32",
    "code": "688739"
  },
  {
    "title": "本周A股解禁规模超500亿元 海尔生物、成大生物、汇宇制药解禁市值居前",
    "href": "http://stock.jrj.com.cn/2022/10/24075537076551.shtml",
    "datetime": "2022-10-24 07:55:15",
    "code": "688739"
  },
  {
    "title": "短期营收承压，成大生物（688739.SH）中长期发展势头向好",
    "href": "http://stock.jrj.com.cn/2022/08/26105236939678.shtml",
    "datetime": "2022-08-26 10:52:57",
    "code": "688739"
  },
  {
    "title": "成大生物(688739)：水痘减毒活疫苗获得药物临床试验批准",
    "href": "http://stock.jrj.com.cn/2022/08/25085936933997.shtml",
    "datetime": "2022-08-25 08:59:36",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：水痘减毒活疫苗获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/08/24161236930571.shtml",
    "datetime": "2022-08-24 16:12:52",
    "code": "688739"
  },
  {
    "title": "成大生物披露2022年半年报 实现营收8.81亿元",
    "href": "http://stock.jrj.com.cn/2022/08/23172436926710.shtml",
    "datetime": "2022-08-23 17:24:29",
    "code": "688739"
  },
  {
    "title": "成大生物：水痘减毒活疫苗临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/06/17105336737156.shtml",
    "datetime": "2022-06-17 10:53:39",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：水痘减毒活疫苗临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/06/16165536734963.shtml",
    "datetime": "2022-06-16 16:55:09",
    "code": "688739"
  },
  {
    "title": "成大生物(688739)：2021年度每10股派发现金红利10元（含税）",
    "href": "http://stock.jrj.com.cn/2022/05/20094736664564.shtml",
    "datetime": "2022-05-20 09:47:56",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)2021年年度权益分派10派10元 股权登记日5月25日",
    "href": "http://stock.jrj.com.cn/2022/05/19175536662866.shtml",
    "datetime": "2022-05-19 17:55:02",
    "code": "688739"
  },
  {
    "title": "成大生物2022年第一季度净利1.51亿同比下滑46.16% 国外市场需求量下滑",
    "href": "http://stock.jrj.com.cn/2022/05/03183236545980.shtml",
    "datetime": "2022-05-03 18:32:42",
    "code": "688739"
  },
  {
    "title": "成大生物披露2022年一季报 实现营收3.66亿元",
    "href": "http://stock.jrj.com.cn/2022/04/29093936501172.shtml",
    "datetime": "2022-04-29 09:39:39",
    "code": "688739"
  },
  {
    "title": "成大生物2021年净利8.92亿同比下滑2.8% 总经理毛昱薪酬158.36万",
    "href": "http://stock.jrj.com.cn/2022/04/15105236342258.shtml",
    "datetime": "2022-04-15 10:52:56",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)2021年度扣非净利润升2.13%至8.63亿元 拟10派10元",
    "href": "http://stock.jrj.com.cn/2022/04/14174736335954.shtml",
    "datetime": "2022-04-14 17:47:50",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：拟投14.02亿元建设生物技术产品研发生产基地项目",
    "href": "http://stock.jrj.com.cn/2022/03/23165734868400.shtml",
    "datetime": "2022-03-23 16:57:58",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：ACYW135群脑膜炎球菌多糖结合疫苗临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/03/16165234834577.shtml",
    "datetime": "2022-03-16 16:52:19",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：十五价HPV疫苗获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/03/15165434829521.shtml",
    "datetime": "2022-03-15 16:54:50",
    "code": "688739"
  },
  {
    "title": "成大生物拟投资5000万设立创业投资基金苏州璞玉创业投资合伙企业（有限合伙） 持股40%",
    "href": "http://stock.jrj.com.cn/2022/03/11201434815516.shtml",
    "datetime": "2022-03-11 20:14:33",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：拟参设创业投资基金 以投向医疗科技及相关周边产业",
    "href": "http://stock.jrj.com.cn/2022/03/11170934814415.shtml",
    "datetime": "2022-03-11 17:09:22",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：本溪子公司取得药品生产许可证",
    "href": "http://stock.jrj.com.cn/2022/03/02165534512541.shtml",
    "datetime": "2022-03-02 16:55:30",
    "code": "688739"
  },
  {
    "title": "增收反降利！成大生物去年归母净利润同比下滑2.80%",
    "href": "http://stock.jrj.com.cn/2022/02/21113634418751.shtml",
    "datetime": "2022-02-21 11:36:25",
    "code": "688739"
  },
  {
    "title": "成大生物2021年净利8.92亿同比减少2.8% 投资公允价值较上年同比减少",
    "href": "http://stock.jrj.com.cn/2022/02/18193234395221.shtml",
    "datetime": "2022-02-18 19:32:37",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)业绩快报：2021年度扣非净利润升2.13%至8.63亿元",
    "href": "http://stock.jrj.com.cn/2022/02/18165534392421.shtml",
    "datetime": "2022-02-18 16:55:07",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：拟斥不超8000万元参与竞拍沈阳一宗工业地",
    "href": "http://stock.jrj.com.cn/2022/02/11154634323469.shtml",
    "datetime": "2022-02-11 15:46:41",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：重组十五价人乳头瘤病毒疫苗(大肠埃希菌)临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/12/15165734019886.shtml",
    "datetime": "2021-12-15 16:57:35",
    "code": "688739"
  },
  {
    "title": "行业观察|疫苗黄金赛道玩家成大生物（688739.SH）：奔向创新",
    "href": "http://stock.jrj.com.cn/2021/11/24155033914321.shtml",
    "datetime": "2021-11-24 15:50:42",
    "code": "688739"
  },
  {
    "title": "成大生物：拟于11月30日召开2021年第一次临时股东大会",
    "href": "http://stock.jrj.com.cn/2021/11/12171333841758.shtml",
    "datetime": "2021-11-12 17:13:50",
    "code": "688739"
  },
  {
    "title": "政策业绩双支撑 狂犬疫苗之王”成大生物成功登陆科创板",
    "href": "http://stock.jrj.com.cn/invest/2021/11/12103633840406.shtml",
    "datetime": "2021-11-12 10:36:00",
    "code": "688739"
  },
  {
    "title": "做疫苗的成大生物为何破发？",
    "href": "http://stock.jrj.com.cn/2021/11/04083933811244.shtml",
    "datetime": "2021-11-04 08:39:21",
    "code": "688739"
  },
  {
    "title": "又见首日破发！成大生物新三板转科创板“出师未捷”",
    "href": "http://stock.jrj.com.cn/2021/10/28103333767622.shtml",
    "datetime": "2021-10-28 10:33:28",
    "code": "688739"
  },
  {
    "title": "A股连续第五天现新股破发，成大生物跌超18%，中一签亏1万元",
    "href": "http://stock.jrj.com.cn/2021/10/28093133767107.shtml",
    "datetime": "2021-10-28 09:31:05",
    "code": "688739"
  },
  {
    "title": "开盘：A股三大指数集体低开沪指跌0.38％，白酒板块领涨，科创板新股成大生物上市破发跌超18％",
    "href": "http://stock.jrj.com.cn/2021/10/28092733767089.shtml",
    "datetime": "2021-10-28 09:27:06",
    "code": "688739"
  },
  {
    "title": "成大生物（688739.SH）：全球人用狂犬病疫苗龙头,“A拆A”登陆科创板",
    "href": "http://stock.jrj.com.cn/2021/10/28091433767029.shtml",
    "datetime": "2021-10-28 09:14:02",
    "code": "688739"
  },
  {
    "title": "辽宁成大：成大生物将于10月28日在科创板上市",
    "href": "http://stock.jrj.com.cn/2021/10/26203233756876.shtml",
    "datetime": "2021-10-26 20:32:27",
    "code": "688739"
  },
  {
    "title": "成大生物披露网上发行中签结果 末“4”位数为2272、7272",
    "href": "http://stock.jrj.com.cn/2021/10/21095033725933.shtml",
    "datetime": "2021-10-21 09:50:12",
    "code": "688739"
  },
  {
    "title": "【兑奖啦】成大生物网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/10/20204333723474.shtml",
    "datetime": "2021-10-20 20:43:12",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)披露中签结果：中签号码共有2.398万个",
    "href": "http://stock.jrj.com.cn/2021/10/20192033723134.shtml",
    "datetime": "2021-10-20 19:20:38",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：网上发行最终中签率为0.02856125%",
    "href": "http://stock.jrj.com.cn/2021/10/19190833717709.shtml",
    "datetime": "2021-10-19 19:08:16",
    "code": "688739"
  },
  {
    "title": "成大生物(688739.SH)：IPO定价为110元/股 10月19日申购",
    "href": "http://stock.jrj.com.cn/2021/10/18140133710326.shtml",
    "datetime": "2021-10-18 14:01:56",
    "code": "688739"
  },
  {
    "title": "次新股说：本批成大生物等值得重点跟踪（2021批次36、37）",
    "href": "http://stock.jrj.com.cn/ipo/2021/09/27083433521764.shtml",
    "datetime": "2021-09-27 08:34:08",
    "code": "688739"
  },
  {
    "title": "A股异动 | 辽宁成大(600739.SH)涨4.56% 证监会同意子公司成大生物科创板IPO注册申请",
    "href": "http://stock.jrj.com.cn/2021/09/15141633439091.shtml",
    "datetime": "2021-09-15 14:16:53",
    "code": "688739"
  },
  {
    "title": "成大生物历时近10个月科创板IPO注册终“通关”，这些企业超半年未被放行原因为何？",
    "href": "http://stock.jrj.com.cn/2021/09/15103733438414.shtml",
    "datetime": "2021-09-15 10:37:43",
    "code": "688739"
  },
  {
    "title": "辽宁成大(600739.SH)：成大生物于科创板IPO获中证监注册",
    "href": "http://stock.jrj.com.cn/2021/09/14202633435330.shtml",
    "datetime": "2021-09-14 20:26:58",
    "code": "688739"
  },
  {
    "title": "辽宁成大：成大生物四价流感病毒裂解疫苗已启动III期临床试验",
    "href": "http://stock.jrj.com.cn/2021/05/27145432829411.shtml",
    "datetime": "2021-05-27 14:54:41",
    "code": "688739"
  },
  {
    "title": "新动态！成大生物、中数智汇科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2021/04/07184532326592.shtml",
    "datetime": "2021-04-07 18:45:47",
    "code": "688739"
  },
  {
    "title": "辽宁成大：成大生物至科创板上市已获得上交所的核准",
    "href": "http://stock.jrj.com.cn/2021/03/25112432214543.shtml",
    "datetime": "2021-03-25 11:24:38",
    "code": "688739"
  },
  {
    "title": "辽宁成大：公司分拆所属子公司辽宁成大生物股份有限公司至科创板上市已获得上交所的核准",
    "href": "http://stock.jrj.com.cn/2021/03/01133432049431.shtml",
    "datetime": "2021-03-01 13:34:21",
    "code": "688739"
  },
  {
    "title": "成大生物药品存一般缺陷8项遭整改 为辽宁成大子公司",
    "href": "http://stock.jrj.com.cn/2020/11/27150031360242.shtml",
    "datetime": "2020-11-27 15:00:00",
    "code": "688739"
  },
  {
    "title": "A拆A众生相：成大生物率先过会 两股未果",
    "href": "http://stock.jrj.com.cn/2020/11/12005431261859.shtml",
    "datetime": "2020-11-12 00:54:40",
    "code": "688739"
  },
  {
    "title": "成大生物：今年科创板过会第131家 中信证券过19单",
    "href": "http://stock.jrj.com.cn/2020/09/28103730852273.shtml",
    "datetime": "2020-09-28 10:37:00",
    "code": "688739"
  },
  {
    "title": "“A拆A”第一股花落成大生物 10家百亿市值药企接踵分拆上市",
    "href": "http://stock.jrj.com.cn/2020/09/28081630857713.shtml",
    "datetime": "2020-09-28 08:16:40",
    "code": "688739"
  },
  {
    "title": "拟募资20.40亿元加码研发 成大生物科创板IPO过会有望成为“A拆A”第一股 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/09/27111230842807.shtml",
    "datetime": "2020-09-27 11:12:01",
    "code": "688739"
  },
  {
    "title": "成大生物IPO过会 A股首单分拆上市花落科创板",
    "href": "http://stock.jrj.com.cn/kcb/2020/09/26034030838647.shtml",
    "datetime": "2020-09-26 03:40:02",
    "code": "688739"
  },
  {
    "title": "成大生物狂犬疫苗收入及毛利占比均超90%",
    "href": "http://stock.jrj.com.cn/kcb/2020/09/22013730805483.shtml",
    "datetime": "2020-09-22 01:37:18",
    "code": "688739"
  },
  {
    "title": "富淼科技、成大生物、银河微电9月25日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/09/17091030767379.shtml",
    "datetime": "2020-09-17 09:10:00",
    "code": "688739"
  },
  {
    "title": "成大生物2020年上半年净利5.24亿增长62% 狂苗收入大幅增长",
    "href": "http://stock.jrj.com.cn/2020/08/10110630464332.shtml",
    "datetime": "2020-08-10 11:06:56",
    "code": "688739"
  },
  {
    "title": "成大生物上半年净利润增长62.11%",
    "href": "http://stock.jrj.com.cn/2020/08/07233330452573.shtml",
    "datetime": "2020-08-07 23:33:54",
    "code": "688739"
  },
  {
    "title": "成大生物2020年上半年预计净利4.85亿-5.33亿 人用狂犬病疫苗产品收入增长",
    "href": "http://stock.jrj.com.cn/2020/07/20204530295515.shtml",
    "datetime": "2020-07-20 20:45:48",
    "code": "688739"
  },
  {
    "title": "折戟港股市场转头闯关科创板 成大生物逆风的上市之路如何走",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/03072030129385.shtml",
    "datetime": "2020-07-03 07:20:06",
    "code": "688739"
  },
  {
    "title": "曾靠行贿疫苗获批 成大生物能否成为“A拆A”第一股？",
    "href": "http://stock.jrj.com.cn/2020/06/15084229924066.shtml",
    "datetime": "2020-06-15 08:42:50",
    "code": "688739"
  },
  {
    "title": "科创板首家境内分拆上市企业获问询 成大生物拟发行4165万股A股",
    "href": "http://stock.jrj.com.cn/2020/06/04120629843473.shtml",
    "datetime": "2020-06-04 12:06:26",
    "code": "688739"
  },
  {
    "title": "成大生物筹备科创板上市：募资加码在研产品管线",
    "href": "http://stock.jrj.com.cn/2020/06/03211229838741.shtml",
    "datetime": "2020-06-03 21:12:12",
    "code": "688739"
  },
  {
    "title": "成大生物拟科创板上市：九成营收源自狂犬病疫苗",
    "href": "http://stock.jrj.com.cn/kcb/2020/06/02074129823986.shtml",
    "datetime": "2020-06-02 07:41:00",
    "code": "688739"
  },
  {
    "title": "五位“种子选手”联袂赶考科创板 成大生物身披诸多光环风头最劲",
    "href": "http://stock.jrj.com.cn/kcb/2020/05/09074729623742.shtml",
    "datetime": "2020-05-09 07:47:03",
    "code": "688739"
  },
  {
    "title": "辽宁成大：拟分拆子公司辽宁成大生物至科创板上市",
    "href": "http://stock.jrj.com.cn/2020/04/02220829179792.shtml",
    "datetime": "2020-04-02 22:08:18",
    "code": "688739"
  },
  {
    "title": "A股公司分拆上市进程加速 辽宁成大披露分拆成大生物上科创板预案",
    "href": "http://stock.jrj.com.cn/2020/04/02215729179737.shtml",
    "datetime": "2020-04-02 21:57:16",
    "code": "688739"
  },
  {
    "title": "辽宁成大发布分拆预案 成大生物拟登陆科创板",
    "href": "http://stock.jrj.com.cn/2020/04/02212329179540.shtml",
    "datetime": "2020-04-02 21:23:00",
    "code": "688739"
  },
  {
    "title": "辽宁成大：拟分拆子公司成大生物至科创板上市",
    "href": "http://stock.jrj.com.cn/2020/04/02191329178493.shtml",
    "datetime": "2020-04-02 19:13:00",
    "code": "688739"
  },
  {
    "title": "辽宁成大：分拆子公司成大生物至科创板上市",
    "href": "http://stock.jrj.com.cn/2020/04/02190629178461.shtml",
    "datetime": "2020-04-02 19:06:00",
    "code": "688739"
  },
  {
    "title": "成大生物2019年净利7.2亿增长15% 销售回款增加",
    "href": "http://stock.jrj.com.cn/2020/03/27193429129421.shtml",
    "datetime": "2020-03-27 19:34:11",
    "code": "688739"
  },
  {
    "title": "成大生物欲闯科创板 曾冲击“三+H”未果",
    "href": "http://stock.jrj.com.cn/kcb/2020/02/26031728893251.shtml",
    "datetime": "2020-02-26 03:17:59",
    "code": "688739"
  },
  {
    "title": "新三板“头牌”成大生物要奔科创板 会是最佳选择吗？",
    "href": "http://stock.jrj.com.cn/2020/02/25222428892713.shtml",
    "datetime": "2020-02-25 22:24:52",
    "code": "688739"
  },
  {
    "title": "辽宁成大拟分拆成大生物科创板上市 两路资本已率先布局",
    "href": "http://stock.jrj.com.cn/2020/02/25195428892121.shtml",
    "datetime": "2020-02-25 19:54:52",
    "code": "688739"
  },
  {
    "title": "成大生物拟科创板上市",
    "href": "http://stock.jrj.com.cn/2020/02/25095128887998.shtml",
    "datetime": "2020-02-25 09:51:01",
    "code": "688739"
  },
  {
    "title": "辽宁成大：控股子公司成大生物决定筹划申请首次公开发行股票并在科创板上市",
    "href": "http://stock.jrj.com.cn/2020/02/25092128887703.shtml",
    "datetime": "2020-02-25 09:21:36",
    "code": "688739"
  },
  {
    "title": "辽宁成大：成大生物筹划申请科创板上市",
    "href": "http://stock.jrj.com.cn/2020/02/25091728887667.shtml",
    "datetime": "2020-02-25 09:17:00",
    "code": "688739"
  },
  {
    "title": "成大生物捐赠壹佰万元助力疫情防控",
    "href": "http://stock.jrj.com.cn/2020/01/27172428737944.shtml",
    "datetime": "2020-01-27 17:24:00",
    "code": "688739"
  },
  {
    "title": "成大生物2019年净利7.2亿 同比增长17.45%",
    "href": "http://stock.jrj.com.cn/2020/01/23123228727111.shtml",
    "datetime": "2020-01-23 12:32:48",
    "code": "688739"
  },
  {
    "title": "成大生物购买5000万理财产品 预期年化收益3.5%",
    "href": "http://stock.jrj.com.cn/2019/11/15134128404405.shtml",
    "datetime": "2019-11-15 13:41:30",
    "code": "688739"
  },
  {
    "title": "成大生物：拟终止H股上市",
    "href": "http://stock.jrj.com.cn/2019/07/30181227904801.shtml",
    "datetime": "2019-07-30 18:12:00",
    "code": "688739"
  },
  {
    "title": "成大生物医学市场总监张怡滨辞职 王焕宇接任",
    "href": "http://stock.jrj.com.cn/2019/07/08075627807704.shtml",
    "datetime": "2019-07-08 07:56:33",
    "code": "688739"
  },
  {
    "title": "新三板公司成大生物发行H股获证监会批准",
    "href": "http://stock.jrj.com.cn/2018/11/23163525398357.shtml",
    "datetime": "2018-11-23 16:35:00",
    "code": "688739"
  },
  {
    "title": "辽宁成大：子公司成大生物向港交所递交上市申请",
    "href": "http://stock.jrj.com.cn/2018/10/31161825286334.shtml",
    "datetime": "2018-10-31 16:18:55",
    "code": "688739"
  },
  {
    "title": "成大生物2018年第三季度盈利同比增长9.27%",
    "href": "http://stock.jrj.com.cn/2018/10/31040025282755.shtml",
    "datetime": "2018-10-31 04:00:35",
    "code": "688739"
  },
  {
    "title": "成大生物2018年第三季度净利润2.24亿元 同比增长9.27%",
    "href": "http://stock.jrj.com.cn/2018/10/30192225281221.shtml",
    "datetime": "2018-10-30 19:22:00",
    "code": "688739"
  },
  {
    "title": "成大生物拟用最高10亿元理财投资 上半年营收6.66亿元",
    "href": "http://stock.jrj.com.cn/2018/10/23154525246418.shtml",
    "datetime": "2018-10-23 15:45:00",
    "code": "688739"
  },
  {
    "title": "成大生物购买1亿元银行理财产品",
    "href": "http://stock.jrj.com.cn/2018/10/22200725239152.shtml",
    "datetime": "2018-10-22 20:07:00",
    "code": "688739"
  },
  {
    "title": "成大生物获冻干人用狂犬病疫苗临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/09/21211625126421.shtml",
    "datetime": "2018-09-21 21:16:00",
    "code": "688739"
  },
  {
    "title": "成大生物2018上半年营收6.66亿元 净利2.99亿元",
    "href": "http://stock.jrj.com.cn/2018/09/18142325107656.shtml",
    "datetime": "2018-09-18 14:23:00",
    "code": "688739"
  },
  {
    "title": "成大生物2018上半年净利润2.99亿元 同比增长14.20%",
    "href": "http://stock.jrj.com.cn/2018/08/31153925032105.shtml",
    "datetime": "2018-08-31 15:39:45",
    "code": "688739"
  },
  {
    "title": "辽宁成大生物拟H股上市 证监会昨日接收材料",
    "href": "http://stock.jrj.com.cn/2018/07/31111024883926.shtml",
    "datetime": "2018-07-31 11:10:00",
    "code": "688739"
  },
  {
    "title": "疫苗事件发酵：A股长生生物多股跌停 新三板成大生物逆势上涨",
    "href": "http://stock.jrj.com.cn/2018/07/23190624851927.shtml",
    "datetime": "2018-07-23 19:06:00",
    "code": "688739"
  },
  {
    "title": "【5月23日新三板收评】做市指数跌0.07% 成大生物成交1399万元",
    "href": "http://stock.jrj.com.cn/2018/05/23152824579705.shtml",
    "datetime": "2018-05-23 15:28:00",
    "code": "688739"
  },
  {
    "title": "5月23日新三板午评：做市指数跌0.50% 成大生物半天成交1334万元",
    "href": "http://stock.jrj.com.cn/2018/05/23115724578833.shtml",
    "datetime": "2018-05-23 11:57:00",
    "code": "688739"
  },
  {
    "title": "受3+H概念影响成大生物开盘后飙升8% 点击网络等成交量放大",
    "href": "http://stock.jrj.com.cn/2018/05/09115924515229.shtml",
    "datetime": "2018-05-09 11:59:00",
    "code": "688739"
  },
  {
    "title": "803家创新层企业一季度盈利",
    "href": "http://stock.jrj.com.cn/2018/05/09025824512546.shtml",
    "datetime": "2018-05-09 02:58:26",
    "code": "688739"
  },
  {
    "title": "5月8日新三板收评：“新三板+H”利好 成大生物连续成交过千万",
    "href": "http://stock.jrj.com.cn/2018/05/08162024510435.shtml",
    "datetime": "2018-05-08 16:20:00",
    "code": "688739"
  },
  {
    "title": "5月8日新三板午评：“新三板+H”加持 成大生物成交再次居首",
    "href": "http://stock.jrj.com.cn/2018/05/08114724509086.shtml",
    "datetime": "2018-05-08 11:47:00",
    "code": "688739"
  },
  {
    "title": "\"三+H\"点燃成大生物，还有这10家概念股，谁更值得关注？",
    "href": "http://stock.jrj.com.cn/2018/05/07211124503881.shtml",
    "datetime": "2018-05-07 21:11:16",
    "code": "688739"
  },
  {
    "title": "5月7日新三板收评：655只个股成交2.6亿元，成大生物成交3360万元居首",
    "href": "http://stock.jrj.com.cn/2018/05/07180324502965.shtml",
    "datetime": "2018-05-07 18:03:00",
    "code": "688739"
  },
  {
    "title": "5月7日新三板午评：成大生物放量成交3030万元",
    "href": "http://stock.jrj.com.cn/2018/05/07114624500789.shtml",
    "datetime": "2018-05-07 11:46:00",
    "code": "688739"
  },
  {
    "title": "成大生物开盘大涨6.8% 公司拟赴港上市成首家3+H公司",
    "href": "http://stock.jrj.com.cn/2018/05/07094724499823.shtml",
    "datetime": "2018-05-07 09:47:00",
    "code": "688739"
  },
  {
    "title": "【新三板早报】成大生物拟发行H股并在港交所上市 远望谷拟近10亿收购龙铁纵横及希奥信息",
    "href": "http://stock.jrj.com.cn/2018/05/07072024498866.shtml",
    "datetime": "2018-05-07 07:20:00",
    "code": "688739"
  },
  {
    "title": "“新三板+H股”落地 成大生物或首吃螃蟹",
    "href": "http://stock.jrj.com.cn/2018/05/07012624498146.shtml",
    "datetime": "2018-05-07 01:26:58",
    "code": "688739"
  },
  {
    "title": "“新三板+H股”第一单将落地！成大生物拟在联交所主板上市！",
    "href": "http://stock.jrj.com.cn/2018/05/04215024495335.shtml",
    "datetime": "2018-05-04 21:50:00",
    "code": "688739"
  },
  {
    "title": "【5月4日新三板重磅消息一览】成大生物拟发行H股并在港交所上市 上市公司远望谷6亿收购龙铁纵横100%股权",
    "href": "http://stock.jrj.com.cn/2018/05/04211224495238.shtml",
    "datetime": "2018-05-04 21:12:00",
    "code": "688739"
  },
  {
    "title": "首家“3+H”公司揭晓！“老三板”成大生物正式开启“新三板+H股”时代",
    "href": "http://stock.jrj.com.cn/2018/05/04205324495158.shtml",
    "datetime": "2018-05-04 20:53:00",
    "code": "688739"
  },
  {
    "title": "重磅！\"三+H\"首单来了，成大生物拟申请在联交所主板上市",
    "href": "http://stock.jrj.com.cn/2018/05/04202424495057.shtml",
    "datetime": "2018-05-04 20:24:32",
    "code": "688739"
  },
  {
    "title": "成大生物董事会通过发行H股并在香港联交所上市议案",
    "href": "http://stock.jrj.com.cn/2018/05/04194524494888.shtml",
    "datetime": "2018-05-04 19:45:00",
    "code": "688739"
  },
  {
    "title": "3+H第一股出炉！成大生物董事会通过港交所上市议案",
    "href": "http://stock.jrj.com.cn/2018/05/04192924494834.shtml",
    "datetime": "2018-05-04 19:29:00",
    "code": "688739"
  },
  {
    "title": "成大生物2017年营收12.76亿元 净赚5.56亿元",
    "href": "http://stock.jrj.com.cn/2018/04/16215624397583.shtml",
    "datetime": "2018-04-16 21:56:00",
    "code": "688739"
  },
  {
    "title": "成大生物2017净利5.56亿 拟分红1.87亿",
    "href": "http://stock.jrj.com.cn/2018/04/16113124394288.shtml",
    "datetime": "2018-04-16 11:31:00",
    "code": "688739"
  },
  {
    "title": "买什么P2P！成大生物一季度分红率就达3%",
    "href": "http://stock.jrj.com.cn/2018/04/14161224390141.shtml",
    "datetime": "2018-04-14 16:12:28",
    "code": "688739"
  },
  {
    "title": "成大生物一季度营收2.5亿 净赚1.1亿元",
    "href": "http://stock.jrj.com.cn/2018/04/13220424388877.shtml",
    "datetime": "2018-04-13 22:04:00",
    "code": "688739"
  },
  {
    "title": "成大生物去年净赚5.56亿 已计提4400万元资产减值准备",
    "href": "http://stock.jrj.com.cn/2018/04/13220424388876.shtml",
    "datetime": "2018-04-13 22:04:00",
    "code": "688739"
  },
  {
    "title": "【4月13日重磅消息一览】狼和医疗拟作价5.2亿元“嫁入”上市公司维力医疗 成大生物2017年净利增长21.61%",
    "href": "http://stock.jrj.com.cn/2018/04/13211424388683.shtml",
    "datetime": "2018-04-13 21:14:00",
    "code": "688739"
  },
  {
    "title": "成大生物今年一季度营收增至2.48亿元",
    "href": "http://stock.jrj.com.cn/2018/04/13175624387941.shtml",
    "datetime": "2018-04-13 17:56:08",
    "code": "688739"
  },
  {
    "title": "成大生物2017年净利5.56亿 同比增长21.61%",
    "href": "http://stock.jrj.com.cn/2018/04/13161724387176.shtml",
    "datetime": "2018-04-13 16:17:00",
    "code": "688739"
  },
  {
    "title": "业绩预增 成大生物拟推员工持股计划，认定核心员工350名",
    "href": "http://stock.jrj.com.cn/2018/02/01213924047706.shtml",
    "datetime": "2018-02-01 21:39:00",
    "code": "688739"
  },
  {
    "title": "成大生物刘蕴华等10名董秘荣膺“中国新三板最受市场认可董秘”",
    "href": "http://stock.jrj.com.cn/2017/12/02160023731097.shtml",
    "datetime": "2017-12-02 16:00:19",
    "code": "688739"
  },
  {
    "title": "成大生物2017年上半年营收5.85亿元 同比增长24.72%",
    "href": "http://stock.jrj.com.cn/2017/08/30175023031535.shtml",
    "datetime": "2017-08-30 17:50:00",
    "code": "688739"
  },
  {
    "title": "成大生物即将挂牌",
    "href": "http://stock.jrj.com.cn/2014/12/31095818632779.shtml",
    "datetime": "2014-12-31 09:58:14",
    "code": "688739"
  },
  {
    "title": "辽宁成大收购成大生物7.72%股权",
    "href": "http://stock.jrj.com.cn/2010/01/2704246876205.shtml",
    "datetime": "2010-01-27 04:24:10",
    "code": "688739"
  }
]